Deal snapshot: TAKEDA WINS JAPAN FAIR TRADE NOD FOR USD 62BN ACQUISITION OF SHIRE.

MANews-(C)2009-2018

Japanese drugmaker Takeda Pharmaceutical Company Ltd. (TSX: 4502) has received unconditional clearance from the Japan Fair Trade Commission for the proposed acquisition of Ireland-based Shire plc (LON: SHP), the company said.

The receipt of antitrust clearance in Japan is another significant step towards closing the transaction. In addition to Japan, the acquisition has now received unconditional clearances from regulatory authorities in multiple key jurisdictions, including the United States, China and Brazil, among others.

Country: UK

Sector: Pharmaceuticals

Target: Shire plc

Buyer: Takeda Pharmaceutical Company

Vendor:

...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT